Horizon Pharma, Inc. (NASDAQ:HZNP)

CAPS Rating 3 out of 5 
HZNP VS S&P 500 (SPY)

HZNP News and Commentary

How do you think HZNP will perform against the market?

Motley Fool CAPS is a community working together to find better stocks and to become better investors.
Powered by: CAPS

All Players

10 Outperform
2 Underperform
 

All-Star Players

2 Outperform
0 Underperform
 

Wall Street

0 Outperform
0 Underperform
 

HZNP Summary

Top HZNP Bull/Bear Pitches

Top Bull Pitch

There are no pitches that meet the Top Bull criteria. Explain

If this upsets you, start recommending pitches below!

Fools bullish on HZNP
are also bullish on:

zzlangerhans (99.67)
Submitted October 24, 2011

I just reviewed Horizon Pharma, who IPO'd in August, and my initial assessment is ... blech. The company markets Lodotra, a programmed release formulation of low dose prednisone, for morning stiffness associated with rheumatoid arthritis. Prednisone… More

Featured Broker Partners


Advertisement